Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29429912

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Mar
First author
Raje N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):277-278. doi: 10.1016/S1470-2045(18)30075-5.
    note
    Source null
    related pmid
    29429916
    relationship
    Comment in

Authors and identifiers

  1. name
    Raje N
    type
    Author
  2. name
    Terpos E
    type
    Author
  3. name
    Willenbacher W
    type
    Author
  4. name
    Shimizu K
    type
    Author
  5. name
    García-Sanz R
    type
    Author
  6. name
    Durie B
    type
    Author
  7. name
    Legieć W
    type
    Author
  8. name
    Krejčí M
    type
    Author
  9. name
    Laribi K
    type
    Author
  10. name
    Zhu L
    type
    Author
  11. name
    Cheng P
    type
    Author
  12. name
    Warner D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Raje N
    type
    Author
  2. name
    Terpos E
    type
    Author
  3. name
    Willenbacher W
    type
    Author
  4. name
    Shimizu K
    type
    Author
  5. name
    García-Sanz R
    type
    Author
  6. name
    Durie B
    type
    Author
  7. name
    Legieć W
    type
    Author
  8. name
    Krejčí M
    type
    Author
  9. name
    Laribi K
    type
    Author
  10. name
    Zhu L
    type
    Author
  11. name
    Cheng P
    type
    Author
  12. name
    Warner D
    type
    Author
bibliography ids
  1. nci-bib-d0c59b99ebf2f0bd8764cbb7
book metadata
content sha256
9843ed8ad60af98cdfe9c294dd9d75fd8a77c227bc302915a6fa5412a71a9e5c
document type
citation
dois
  1. 10.1016/S1470-2045(18)30072-X
electronic publication date
display
2018 Feb 9
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29429912
immutable id
pubmed:29429912@9843ed8ad60af98cdfe9c294dd9d75fd8a77c227bc302915a6fa5412a71a9e5c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
370-381
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):277-278. doi: 10.1016/S1470-2045(18)30075-5.
    note
    Source null
    related pmid
    29429916
    relationship
    Comment in
outcomes validated
false
pmid
29429912
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
01157f0104975904cb7ffa6f5d361805e4a8576585cda423815b0aa883d006bd
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
  7. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29429912/
title
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

Preserved source evidence · Not medical advice